US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology Industry Research & Market Reports

12  13  14  15    17    19  20  21  
Drug Delivery Technologies Market Forecast 2014-2024
4/30/2014 | published by: Visiongain
... this market and related technologies? Visiongain’s new report shows you potential revenues and other trends to 2024, discussing data, opportunities and prospects. Our 202 page report provides 157 tables, charts, and graphs. Discover the most ...  |  read more...
USD 3,004
Biologics - Next-Generation Biologics: R&D, Industry and Market 2014-2024
4/2/2014 | published by: Visiongain
... attract potential billion-dollar deals with pharmaceutical partners, with up-front fees in excess of $100m. This demonstrates a confidence in the technology from the pharmaceutical industry. In the second half of the period 2014-2024, submarket growth ...  |  read more...
USD 3,004
Miltenyi Biotec GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
6/18/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Miltenyi Biotec GmbH Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Dermatological Drugs Market Forecast 2014-2024
4/15/2014 | published by: Visiongain
... limited by slow economic growth. In 2011, a fall in total spending was noted by the Spanish health ministry. The market will be restrained by recent financial problems and laws introduced by the Spanish government ...  |  read more...
USD 3,004
Research and Forecast on China Insulin Market, 2014-2018
4/15/2014 | published by: Huidian Research
... of China Insulin Market. A survey conducted by Huidian Research shows that China’s insulin market scale approximately registered CNY 11 billion in 2013, of which CNY 7.5 billion achieved in second-generation insulin market and CNY ...  |  read more...
USD 1,800
WHAT U.S. CONSUMERS REALLY THINK OF GMOs!
6/15/2014 | published by: Natural Marketing Institute
... past, NMI found widespread confusion about GMOs, the amount of recent media exposure on the subject has fueled consumer understanding and concerns. The objective of this current report is to provide an updated review of ...  |  read more...
USD 3,500
Creatine Kinase (CK): 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations France, Germany, Italy, Japan, Spain, UK, USA
6/16/2014 | published by: Venture Planning Group
... Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratories POC/Decentralized Testing - Physician Offices/Group Practices - Ambulatory Care Centers - Emergency Departments - ICUs/CCUs List of ...  |  read more...
USD 750
Biomaterials China News 1404
4/28/2014 | published by: CCM International Limited
... price of corn has been fluctuating and increasing slightly since Mar. 2014, due to the governmental policy on purchase and storage and impact from main production bases like northeast China and North China. Of this, ...  |  read more...
USD 2,916
Amarantus Bioscience Holdings, Inc. (AMBS) - Product Pipeline Analysis, 2014 Update
5/14/2014 | published by: GlobalData
... offers treatment services for neurodegenerative diseases such as Parkinson’s disease, ALS and alzheimer’s disease, and cardiovascular diseases including myocardial infarction, coronary artery disease and heart failure. The company holds license to Eltoprazine, owns intellectual property ...  |  read more...
USD 750
Bioheart, Inc. (BHRT) - Product Pipeline Analysis, 2014 Update
5/14/2014 | published by: GlobalData
... Adipocell. Myocell is a muscle stem cell theraphy that intends to improve the cardiac function of a damaged heart after a severe heart attack Myocell SDF-1 is an improved version of Myocell. Here the myoblast ...  |  read more...
USD 750
BioMimetic Therapeutics, Inc. - Product Pipeline Analysis, 2014 Update
5/16/2014 | published by: GlobalData
... based upon the recombinant human platelet-derived growth factor (rhPDGF-BB) in combination with tissue specific matrices as its primary technology platform for promotion of tissue healing and regeneration. The company’s range of products and product candidates ...  |  read more...
USD 750
Caprion Inc. - Product Pipeline Analysis, 2014 Update
5/16/2014 | published by: GlobalData
... validation of biomarkers using its proteomics discovery platform CellCarta. Caprion’s CellCarta is used in profiling proteins in solid tissues and plasma. It develops in-vitro diagnostic product candidates in the areas of infectious diseases, oncology and ...  |  read more...
USD 750
ImmunoCellular Therapeutics, Ltd. (IMUC) - Financial and Strategic SWOT Analysis Review
4/29/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Life Technologies Corporation (LIFE) - Financial and Strategic SWOT Analysis Review
4/29/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Lpath, Inc. (LPTN) - Financial and Strategic SWOT Analysis Review
5/15/2014 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 125
Macrogen Inc. (038290) - Financial and Strategic SWOT Analysis Review
5/15/2014 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 125
Monogram Biosciences, Inc. - Strategic SWOT Analysis Review
5/15/2014 | published by: GlobalData
... employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope Business ...  |  read more...
USD 125
Mymetics Corporation (MYMX) - Financial and Strategic SWOT Analysis Review
5/15/2014 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 125
Myriad Genetics, Inc. (MYGN) - Product Pipeline Analysis, 2014 Update
5/16/2014 | published by: GlobalData
... through the treatment decisions. Its product portfolio iincludes nine commercial molecular diagnostic tests, namely, six predictive medicine tests; one prognostic medicine test; and two personalized medicine tests in the areas of oncology and CNS related ...  |  read more...
USD 750
Oncolytics Biotech Inc. (ONC) - Financial and Strategic SWOT Analysis Review
5/15/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Probi AB (PROB) - Financial and Strategic SWOT Analysis Review
5/15/2014 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 125
Genentech, Inc. - Product Pipeline Analysis, 2014 Update
5/16/2014 | published by: GlobalData
... of cancer, immunological diseases and angiogenic disorders. Some of its major products include Rituxan, Avastin, Herceptin, Tarceva, Lucentis, Xolair, Pulmozyme and Activase. Its research activities focus on areas of cancer, metabolism, immunology, infectious disease and ...  |  read more...
USD 750
ROG – Penzberg Biologic Manufacturing Facility – Bavaria - Construction Project Profile
5/22/2014 | published by: World Market Intelligence
... including project overview and location. The profile also details project ownership and funding, gives a full project description, as well as information on contracts, tendering and key project contacts. World "ROG – Penzberg Biologic Manufacturing ...  |  read more...
USD 75
Unnatural Amino Acids
4/1/2014 | published by: RI Technologies
... D-Amino Acid Derivatives, DL-Amino Acids, DL-Amino Acid Derivatives, L-Amino Acid Derivatives and Other ) and their application areas such as R&D, Pharmaceutical, Food & Feed, Agrochemicals and Other. The study includes estimations and predictions for ...  |  read more...
USD 8,100
Oxygen Biotherapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
4/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Oxygen Biotherapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
12  13  14  15    17    19  20  21